logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/07/2025
At a press conference at the State Council Information Office, Yuan Da, Secretary General of the National Development and Reform Commission, stated that by 2024, China will have accumulated more than 4,000 innovative drugs under research, accounting for approximately 30% of the global total.
Latest
1 m ago
Kang Chen Pharmaceutical (01681.HK) spent approximately HKD 5.4584 million on July 9 to repurchase 48.9 thousand shares.
2 m ago
NIO-SW (09866.HK) has reached 1,000 highway swapping stations, with over 8,000 charging and swapping stations nationwide.
3 m ago
Tencent Holdings (00700.HK) spent 500 million Hong Kong dollars on July 9th to buy back 1,005,000 shares.
3 m ago
According to NTV: The Turkish Minister of Transport stated that, if necessary, they will fully block access to the social media platform "X" and will contact "X" regarding this matter.
3 m ago
"Milkshop" and "Naixue Tea" supplier Chairman disciplined.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.